Towards a scalable HIV cure research agenda: the role of co-infections

The development of a cure is among the foremost contemporary priorities in the field of HIV research. The science that underpins a potential HIV cure should be generalisable to the many millions of persons globally who enter antiretroviral treatment programs with advanced immunosuppression and/or an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereti, Irini, Folkers, Gregory K, Meintjes, Graeme, Boulware, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2015
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739889/
https://www.ncbi.nlm.nih.gov/pubmed/26855972
_version_ 1782413801917775872
author Sereti, Irini
Folkers, Gregory K
Meintjes, Graeme
Boulware, David R
author_facet Sereti, Irini
Folkers, Gregory K
Meintjes, Graeme
Boulware, David R
author_sort Sereti, Irini
collection PubMed
description The development of a cure is among the foremost contemporary priorities in the field of HIV research. The science that underpins a potential HIV cure should be generalisable to the many millions of persons globally who enter antiretroviral treatment programs with advanced immunosuppression and/or an opportunistic infection. We provide five key suggestions for incorporation into the HIV cure research agenda to maximise the generalisability and applicability of an HIV cure once developed.
format Online
Article
Text
id pubmed-4739889
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Mediscript Ltd
record_format MEDLINE/PubMed
spelling pubmed-47398892016-02-04 Towards a scalable HIV cure research agenda: the role of co-infections Sereti, Irini Folkers, Gregory K Meintjes, Graeme Boulware, David R J Virus Erad Viewpoint The development of a cure is among the foremost contemporary priorities in the field of HIV research. The science that underpins a potential HIV cure should be generalisable to the many millions of persons globally who enter antiretroviral treatment programs with advanced immunosuppression and/or an opportunistic infection. We provide five key suggestions for incorporation into the HIV cure research agenda to maximise the generalisability and applicability of an HIV cure once developed. Mediscript Ltd 2015-10-01 /pmc/articles/PMC4739889/ /pubmed/26855972 Text en © 2015 The Authors. Journal of Virus Eradication published by Mediscript Ltd http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article published under the terms of a Creative Commons License.
spellingShingle Viewpoint
Sereti, Irini
Folkers, Gregory K
Meintjes, Graeme
Boulware, David R
Towards a scalable HIV cure research agenda: the role of co-infections
title Towards a scalable HIV cure research agenda: the role of co-infections
title_full Towards a scalable HIV cure research agenda: the role of co-infections
title_fullStr Towards a scalable HIV cure research agenda: the role of co-infections
title_full_unstemmed Towards a scalable HIV cure research agenda: the role of co-infections
title_short Towards a scalable HIV cure research agenda: the role of co-infections
title_sort towards a scalable hiv cure research agenda: the role of co-infections
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739889/
https://www.ncbi.nlm.nih.gov/pubmed/26855972
work_keys_str_mv AT seretiirini towardsascalablehivcureresearchagendatheroleofcoinfections
AT folkersgregoryk towardsascalablehivcureresearchagendatheroleofcoinfections
AT meintjesgraeme towardsascalablehivcureresearchagendatheroleofcoinfections
AT boulwaredavidr towardsascalablehivcureresearchagendatheroleofcoinfections

Ejemplares similares